Podcast
Questions and Answers
What is the primary characteristic of Glecaprevir/pibrentasvir for treating Hepatitis C?
What is the primary characteristic of Glecaprevir/pibrentasvir for treating Hepatitis C?
Which of the following statements about Hepatitis C treatment is accurate?
Which of the following statements about Hepatitis C treatment is accurate?
What is the recommended dosing regimen for Glecaprevir/pibrentasvir?
What is the recommended dosing regimen for Glecaprevir/pibrentasvir?
In which scenario should Glecaprevir/pibrentasvir be contraindicated?
In which scenario should Glecaprevir/pibrentasvir be contraindicated?
Signup and view all the answers
What is a common adverse drug reaction (ADR) associated with Glecaprevir/pibrentasvir?
What is a common adverse drug reaction (ADR) associated with Glecaprevir/pibrentasvir?
Signup and view all the answers
Which Hepatitis type is known to have a vaccine available?
Which Hepatitis type is known to have a vaccine available?
Signup and view all the answers
How is Hepatitis C primarily transmitted?
How is Hepatitis C primarily transmitted?
Signup and view all the answers
What parameter is crucial for monitoring during Hepatitis C treatment?
What parameter is crucial for monitoring during Hepatitis C treatment?
Signup and view all the answers
What is the estimated cost of therapy for Mavyret over an 8-week duration?
What is the estimated cost of therapy for Mavyret over an 8-week duration?
Signup and view all the answers
Which HCV medication has the highest estimated cost for its treatment duration?
Which HCV medication has the highest estimated cost for its treatment duration?
Signup and view all the answers
What ICD-10 code is associated with the prior-authorization process for HCV?
What ICD-10 code is associated with the prior-authorization process for HCV?
Signup and view all the answers
Which of the following therapies costs the same as Epclusa?
Which of the following therapies costs the same as Epclusa?
Signup and view all the answers
What is a critical aspect of the HCV treatment process indicated in the document?
What is a critical aspect of the HCV treatment process indicated in the document?
Signup and view all the answers
Which statement about the prior-authorization process is accurate?
Which statement about the prior-authorization process is accurate?
Signup and view all the answers
What is the estimated cost of therapy for Zepatier over 12 weeks?
What is the estimated cost of therapy for Zepatier over 12 weeks?
Signup and view all the answers
In which month and year was the Rebetol package insert published?
In which month and year was the Rebetol package insert published?
Signup and view all the answers
Which of the following is true regarding Sofosbuvir/velpatasvir (Epclusa)?
Which of the following is true regarding Sofosbuvir/velpatasvir (Epclusa)?
Signup and view all the answers
What is the appropriate dosing schedule for Sofosbuvir/velpatasvir/voxilaprevir (Vosevi) for the treatment of HCV?
What is the appropriate dosing schedule for Sofosbuvir/velpatasvir/voxilaprevir (Vosevi) for the treatment of HCV?
Signup and view all the answers
What common adverse drug reactions (ADRs) are associated with Sofosbuvir/velpatasvir (Epclusa)?
What common adverse drug reactions (ADRs) are associated with Sofosbuvir/velpatasvir (Epclusa)?
Signup and view all the answers
In which patient population is Sofosbuvir/velpatasvir/voxilaprevir (Vosevi) preferred treatment?
In which patient population is Sofosbuvir/velpatasvir/voxilaprevir (Vosevi) preferred treatment?
Signup and view all the answers
What is the significance of the FDA warning regarding Sofosbuvir/velpatasvir (Epclusa) and other therapies?
What is the significance of the FDA warning regarding Sofosbuvir/velpatasvir (Epclusa) and other therapies?
Signup and view all the answers
What is the role of ribavirin (RBV) when used with Sofosbuvir/velpatasvir (Epclusa) in specific conditions?
What is the role of ribavirin (RBV) when used with Sofosbuvir/velpatasvir (Epclusa) in specific conditions?
Signup and view all the answers
Which of the following statements correctly identifies a difference between Sofosbuvir and Sofosbuvir/velpatasvir?
Which of the following statements correctly identifies a difference between Sofosbuvir and Sofosbuvir/velpatasvir?
Signup and view all the answers
What precaution should be taken with acid suppressive therapy in patients receiving Sofosbuvir/velpatasvir (Epclusa)?
What precaution should be taken with acid suppressive therapy in patients receiving Sofosbuvir/velpatasvir (Epclusa)?
Signup and view all the answers
What is the primary mechanism of action for Ribavirin?
What is the primary mechanism of action for Ribavirin?
Signup and view all the answers
Which of the following patient conditions does NOT warrant a dosage adjustment for Ribavirin?
Which of the following patient conditions does NOT warrant a dosage adjustment for Ribavirin?
Signup and view all the answers
For a patient weighing 80 kg, what would be the appropriate daily dosage of Ribavirin?
For a patient weighing 80 kg, what would be the appropriate daily dosage of Ribavirin?
Signup and view all the answers
Which of the following is a contraindication for Ribavirin use?
Which of the following is a contraindication for Ribavirin use?
Signup and view all the answers
Under which circumstance should Ribavirin be discontinued according to dosing guidelines?
Under which circumstance should Ribavirin be discontinued according to dosing guidelines?
Signup and view all the answers
What is a black box warning associated with Ribavirin?
What is a black box warning associated with Ribavirin?
Signup and view all the answers
What is the recommended dosing schedule for a patient who weighs 70 kg?
What is the recommended dosing schedule for a patient who weighs 70 kg?
Signup and view all the answers
What is the half-life of Ribavirin when used in treating HCV?
What is the half-life of Ribavirin when used in treating HCV?
Signup and view all the answers
What characterized the historical response rates of co-infected patients treated with DAAs compared to previous treatments?
What characterized the historical response rates of co-infected patients treated with DAAs compared to previous treatments?
Signup and view all the answers
Which factor could contribute to greater liver-related mortality in HIV patients?
Which factor could contribute to greater liver-related mortality in HIV patients?
Signup and view all the answers
What effect do acid reducers have on the absorption of Ledipasvir and Velpatasvir?
What effect do acid reducers have on the absorption of Ledipasvir and Velpatasvir?
Signup and view all the answers
What is the recommended separation time for taking antacids with Harvoni?
What is the recommended separation time for taking antacids with Harvoni?
Signup and view all the answers
Which of the following drug classes is NOT associated with clinically important interactions with DAAs?
Which of the following drug classes is NOT associated with clinically important interactions with DAAs?
Signup and view all the answers
How should H2 antagonists be administered when taken with LDV/VEL?
How should H2 antagonists be administered when taken with LDV/VEL?
Signup and view all the answers
What is a notable complication of HCV co-infection in relation to HIV progression?
What is a notable complication of HCV co-infection in relation to HIV progression?
Signup and view all the answers
Which of the following is a recommendation for administering proton pump inhibitors with LDV?
Which of the following is a recommendation for administering proton pump inhibitors with LDV?
Signup and view all the answers
Study Notes
Objectives of Hepatitis C Management
- Understand characteristics of direct-acting antivirals (DAAs) for Hepatitis C (HCV).
- Monitor parameters before, during, and after treatment.
- Select preferred treatment regimens based on patient history and cost.
- Adapt treatment strategies for special populations with HCV.
Types of Viral Hepatitis Infections
- Hepatitis A: Transmitted via fecal/oral route, no treatment, vaccine available, no chronicity.
- Hepatitis B: Transmitted through permucosal/percutaneous methods, treated, vaccine available, can lead to chronic infection in neonates.
- Hepatitis C: Transmitted via permucosal/percutaneous routes, treatable, no vaccine, potential for chronic infection in neonates.
- Hepatitis D: Requires Hepatitis B for transmission; leads to chronicity when co-infected.
- Hepatitis E: Transmitted via fecal/oral route, no treatment or vaccine available, no chronicity.
Direct Acting Antivirals (DAAs) for HCV
-
Glecaprevir/Pibrentasvir (Mavyret):
- Pangenotypic, dosed once daily with food for 8 weeks.
- Common side effects include headache and fatigue (10%).
- Contraindicated in moderate-severe hepatic impairment.
-
Sofosbuvir/Velpatasvir (Epclusa):
- Pangenotypic, preferred for decompensated cirrhosis, taken daily for 12 weeks.
- Common side effects include headache and fatigue (10%).
- Should avoid acid suppressive therapy.
-
Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi):
- Pangenotypic, used for patients with decompensated cirrhosis, dosed once daily for 12 weeks.
- Common side effects: headache, diarrhea, nausea (10%); includes use as salvage therapy.
-
Sofosbuvir (Sovaldi):
- Used in combination with other DAAs; effective for various genotypes.
- Common side effects: fatigue, headache, nausea.
Ribavirin
- Directly inhibits HCV RNA polymerase, minimal effect when used alone.
- Dosing varies based on weight, with specific adjustments for hemoglobin levels.
- Contraindications include pregnancy, unstable cardiac disease, and renal dysfunction.
Drug Interactions
- Significant interactions with various medications: statins, anticonvulsants, and estrogens noted.
- Acid reducers decrease absorption of specific DAAs; dosing guidelines provided for antacids, H2 antagonists, and PPIs.
Special Considerations
- HCV screening recommended for all HIV patients due to co-infection risks.
- Challenges in drug access and prior authorization involve time-consuming paperwork.
Cost of HCV Treatments
- Estimated costs for various therapies (2019 estimates):
- Mavyret: $26,400 for 8 weeks
- Harvoni: $94,500 for 12 weeks
- Epclusa and Vosevi: $74,760 for 12 weeks
- Zepatier: $54,600 for 12 weeks.
Safety Warnings
- Ribavirin carries black box warnings for hemolytic anemia and teratogenicity, necessitating caution in certain populations.
Monitoring and Adjustments
- Pre-treatment evaluations and ongoing monitoring are crucial to ensure safety and efficacy during therapy.
- Adjust medication regimens based on patient response and side effects throughout treatment.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz focuses on the management of Hepatitis C, emphasizing the characteristics of direct acting antivirals. Participants will learn about pre-treatment, on-treatment, and post-treatment monitoring parameters, as well as how to select preferred treatment regimens based on patient history and other factors.